Intrexon Corp (XON):企業の財務・戦略的SWOT分析

◆英語タイトル:Intrexon Corp (XON) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14917
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Intrexon Corp (Intrexon), formerly Genomatix Corp is a synthetic biology service provider. The company operates through its divisions and units such as cell engineering, data sciences and computational biology, information technology (IT), actobiotics, molecular engineering, agricultural biotech, animal sciences, and industrial products division. Its cell engineering unit designs and creates cell systems and optimize processes for the development of biologically based products to address unmet market needs. Intrexon’s IT division includes infrastructure, software engineering, and information systems. The company’s agricultural biotech division provides food and feed crops for a variety of applications in agriculture. It has partnership with the channel of network collaborators and joint ventures to commercialize its technologies. Intrexon is headquartered in Blacksburg, Virginia, the US.

Intrexon Corp Key Recent Developments

Feb 28,2019: Intrexon reports 2018 fourth quarter and year end financial results
Nov 28,2018: Oxitec Transitioning Friendly™ Self-limiting Mosquitoes to 2nd Generation Technology Platform, Paving Way to New Scalability, Performance and Cost Breakthroughs
Nov 08,2018: Intrexon announces third quarter 2018 financial results
Oct 29,2018: ActoBio Therapeutics Doses First Patient in Phase Ib/IIa Clinical Study of AG019 for the Treatment of Type 1 Diabetes
Oct 24,2018: Intrexon announces the formation of bioinformatics hub in Munich

This comprehensive SWOT profile of Intrexon Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Intrexon Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Intrexon Corp – Key Information
Intrexon Corp – Overview
Intrexon Corp – Key Employees
Intrexon Corp – Key Employee Biographies
Intrexon Corp – Key Operational Heads
Intrexon Corp – Major Products and Services
Intrexon Corp – History
Intrexon Corp – Company Statement
Intrexon Corp – Locations And Subsidiaries
Intrexon Corp – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Intrexon Corp – Business Description
Intrexon Corp – Corporate Strategy
Intrexon Corp – SWOT Analysis
SWOT Analysis – Overview
Intrexon Corp – Strengths
Intrexon Corp – Weaknesses
Intrexon Corp – Opportunities
Intrexon Corp – Threats
Intrexon Corp – Key Competitors

Section 3 – Company Financial Performance Charts

Intrexon Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Intrexon Corp, Key Information
Intrexon Corp, Key Ratios
Intrexon Corp, Share Data
Intrexon Corp, Major Products and Services
Intrexon Corp, History
Intrexon Corp, Key Employees
Intrexon Corp, Key Employee Biographies
Intrexon Corp, Key Operational Heads
Intrexon Corp, Other Locations
Intrexon Corp, Subsidiaries
Intrexon Corp, Key Manufacturing facilities
Intrexon Corp, Key Competitors
Intrexon Corp, SWOT Analysis
Intrexon Corp, Ratios based on current share price
Intrexon Corp, Annual Ratios
Intrexon Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Intrexon Corp, Performance Chart
Intrexon Corp, Ratio Charts

★海外企業調査レポート[Intrexon Corp (XON):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Taiflex Scientific Co., Ltd. (8039):企業の財務・戦略的SWOT分析
    Taiflex Scientific Co., Ltd. (8039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Coloplast A/S:戦略・SWOT・企業財務分析
    Coloplast A/S - Strategy, SWOT and Corporate Finance Report Summary Coloplast A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ind-Swift Laboratories Ltd (INDSWFTLAB):企業の財務・戦略的SWOT分析
    Summary Ind-Swift Laboratories Ltd (ISLL) is a manufacturer of active pharmaceutical ingredients and custom chemical products. Its products portfolio includes API’s and finished dosage forms in the therapeutic categories of macrolide antibiotic, antidiabetic, antimigraine, parkinson's disease, antin …
  • SK Holdings Co Ltd (034730):企業の財務・戦略的SWOT分析
    SK Holdings Co Ltd (034730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Vaxart Inc (AVIR):企業の財務・戦略的SWOT分析
    Vaxart Inc (AVIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mayne Pharma Group Ltd (MYX):企業の財務・戦略的SWOT分析
    Summary Mayne Pharma Group Ltd (Mayne Pharma) formerly HalcyGen Pharmaceuticals Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company offers products such as erymax capsules, kapanol capsules, doryx capsules, magnoplasm, astrix c …
  • Yokogawa Electric Corp (6841):石油・ガス:M&Aディール及び事業提携情報
    Summary Yokogawa Electric Corp (Yokogawa) is an industrial automation company. It manufactures and supplies products and solutions in measurement, control, and information technologies fields. The company’s product offering include differential pressure/pressure transmitters, flow meters, and proces …
  • Singapore Telecommunications Ltd (Z74):企業の財務・戦略的SWOT分析
    Singapore Telecommunications Ltd (Z74) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Australian Securities & Investments Commission:企業の戦略的SWOT分析
    Australian Securities & Investments Commission - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Sembcorp Industries Ltd (U96):企業の財務・戦略的SWOT分析
    Sembcorp Industries Ltd (U96) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Osiris Therapeutics Inc (OSIR):企業の財務・戦略的SWOT分析
    Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Smiths Group plc:企業の戦略・SWOT・財務情報
    Smiths Group plc - Strategy, SWOT and Corporate Finance Report Summary Smiths Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Color Genomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Color Genomics, Inc. (Color) provides physician ordered genetic testing service that helps to identify hereditary cancer risk. The company’s clinical grade test provides actionable results that enable consumers and their doctors to create personalized screening and healthcare plan. Color ana …
  • Pinnacle Investment Management Group Limited (PNI):企業の財務・戦略的SWOT分析
    Pinnacle Investment Management Group Limited (PNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • PGS ASA (PGS):企業の財務・戦略的SWOT分析
    PGS ASA (PGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Compumedics Ltd (CMP):企業の財務・戦略的SWOT分析
    Summary Compumedics Ltd (Compumedics) is a medical device company that develops and commercializes computer-based medical products. The company designs, develops and commercializes computer aided medical diagnostic systems. It provides product categories such as sleep diagnostics, neurology diagnost …
  • Hobby Lobby Stores Inc:企業の戦略・SWOT・財務情報
    Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Immunodiagnostic Systems Holdings plc (IDH)-医療機器分野:企業M&A・提携分析
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • Immunocore Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Immunocore Ltd (Immunocore) is a biotechnology company that focuses on the development of immunotherapeutic drugs for the treatment of cancer, infectious diseases and autoimmune diseases. The company develops its drugs using its proprietary T cell receptor (TCR) technology. Its products unde …
  • Tribune Media Co:企業の戦略的SWOT分析
    Tribune Media Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆